Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Three-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics, and Preliminary Efficacy Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair

Next Previous
X
Search
Trial Profile

A Three-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics, and Preliminary Efficacy Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 16 Sep 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Vocacapsaicin (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Concentric Analgesics

    • Most Recent Events

    • 02 Apr 2022 Primary endpoint (Pain -measured using a numerical rating score (NRS) with activity and ambulation and at rest.) has not been met as per results presented at 47th Annual Regional Anesthesiology and Acute Pain Medicine Meeting in Las Vegas, Nevada
    • 02 Apr 2022 Primary endpoint (Pain- measured using a numerical rating score (NRS) with activity coughing) has been met as per results presented at 47th Annual Regional Anesthesiology and Acute Pain Medicine Meeting in Las Vegas, Nevada
    • 02 Apr 2022 Results presented at 47th Annual Regional Anesthesiology and Acute Pain Medicine Meeting in Las Vegas, Nevada
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top